- Home
- FBK vs KYMR Comparison
FBK vs KYMR Comparison
Compare FBK & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- KYMR
- Stock Information
- Founded
- FBK 1906
- KYMR 2015
- Country
- FBK United States
- KYMR United States
- Employees
- FBK N/A
- KYMR N/A
- Industry
- FBK Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- FBK Finance
- KYMR Health Care
- Exchange
- FBK Nasdaq
- KYMR Nasdaq
- Market Cap
- FBK 2.0B
- KYMR 1.8B
- IPO Year
- FBK 2016
- KYMR 2020
- Fundamental
- Price
- FBK $45.22
- KYMR $30.07
- Analyst Decision
- FBK Hold
- KYMR Buy
- Analyst Count
- FBK 5
- KYMR 13
- Target Price
- FBK $54.00
- KYMR $56.69
- AVG Volume (30 Days)
- FBK 288.8K
- KYMR 704.0K
- Earning Date
- FBK 04-14-2025
- KYMR 05-09-2025
- Dividend Yield
- FBK 1.68%
- KYMR N/A
- EPS Growth
- FBK 14.69
- KYMR N/A
- EPS
- FBK 2.73
- KYMR N/A
- Revenue
- FBK $465,280,000.00
- KYMR $58,885,000.00
- Revenue This Year
- FBK $35.47
- KYMR $16.24
- Revenue Next Year
- FBK $20.14
- KYMR $22.41
- P/E Ratio
- FBK $16.57
- KYMR N/A
- Revenue Growth
- FBK 2.18
- KYMR N/A
- 52 Week Low
- FBK $34.50
- KYMR $19.45
- 52 Week High
- FBK $58.88
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- FBK 58.36
- KYMR 49.08
- Support Level
- FBK $43.73
- KYMR $28.28
- Resistance Level
- FBK $45.78
- KYMR $35.98
- Average True Range (ATR)
- FBK 1.03
- KYMR 2.26
- MACD
- FBK 0.56
- KYMR -0.10
- Stochastic Oscillator
- FBK 90.00
- KYMR 30.31
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.